Sample No | Sex | Age (years) | Tumor size (cm) | BRAF mutation | Tumor stage | Node stage | Clinical stage |
---|---|---|---|---|---|---|---|
PTC-1 | Female | 60 | 1.0 × 0.7 × 0.3 |  +  | T1 | N0 | I |
PTC-2 | Female | 33 | 2.2 × 1.4 × 1.4 |  +  | T2 | N1a | I |
PTC-3 | Male | 34 | 1.9 × 1.5 × 1.2 |  +  | T1b | N1a | I |
PTC-4 | Male | 33 | 3.0 × 2.4 × 1.6 |  +  | T3 | N0 | I |
PTC-5 | Male | 20 | 1.9 × 1.6 × 1.0 |  +  | T1b | N1b | I |
PTC-6 | Female | 28 | 3.5 × 2.3 × 1.8 |  − | T2 | N1b | I |
PTC-7 | Female | 31 | 2.5 × 2.0 × 2.0 |  − | T2 | N0 | I |
PTC-8 | Female | 27 | 2.1 × 1.6 × 1.5 |  − | T1b | N1a | I |
PTC-9 | Male | 32 | 3.5 × 3.0 × 3.0 |  − | T2 | N1 | I |